Less than six months after Mayo Clinic president and CEO Dr. John Noseworthy announced plans to step down at the end of 2018, the Rochester, Minnesota health system has selected Dr. Gianrico Farrugia as Noseworthy’s successor.
Farrugia currently serves as vice president of Mayo Clinic and CEO of Mayo Clinic in Florida, a position he has held since January 2015.
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Previously, he was a director of Mayo’s Center for Individualized Medicine. Farrugia, a Malta native who’s spent 30 years as a Mayo doctor, was also co-founder of the Mayo Clinic Center for Innovation.
Having earned his medical degree at the University of Malta Medical School, Farrugia is now appointed in the Division of Gastroenterology and Hepatology, the Department of Internal Medicine and the Department of Physiology and Biomedical Engineering.
He has written over 250 articles on genomics and the treatment of disorders of gastrointestinal motility and co-authored the book Think Big, Start Small, Move Fast: A Blueprint for Transformation From the Mayo Clinic Center for Innovation.
In a statement, Farrugia commented on his appointment:
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
I am humbled and proud to follow and build upon this success with the best staff in the world. While sea change continues to sweep through healthcare, I look forward to harnessing innovation, a hallmark of Mayo Clinic, to transform healthcare for the benefit of patients everywhere.
Noseworthy and Farrugia will work together during the transition process.
The search process for Farrugia was spearheaded by a committee comprised of Mayo’s board of governors and its board of trustees. These individuals also gathered insight from senior leaders and physicians at Mayo Clinic.
The leadership switch-up in Minnesota isn’t the only high-profile hospital CEO change as of late. In May 2017, Cleveland Clinic’s Dr. Toby Cosgrove unveiled his intention to step down. Four months later, the Ohio health system named his successor: Dr. Tomislav “Tom” Mihaljevic, who served as CEO of Cleveland Clinic Abu Dhabi at the time. Mihaljevic took the helm at Cleveland Clinic on January 1 of this year.
Photo: z_wei, Getty Images